Article
N-acetylcysteine Supplementation Improves Endocrine-Metabolism Profiles and Ovulation Induction Efficacy in Polycystic Ovary Syndrome
2024-06-12
Abstract excerpt
<title>Abstract</title> <p>Background Polycystic ovary syndrome (PCOS) affects 6–20% of women worldwide, with insulin resistance and hyperinsulinemia occurring in 50%-70% of patients. Hyperinsulinemia exacerbates oxidative stress, contributing to PCOS pathogenesis. N-acetylcysteine (NAC) is an antioxidant and insulin sensitizer that shows promise as a therapeutic for PCOS. Our current study aimed to investigate...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e634acf5-4521-58b5-8b0c-9e5ea8c9c59e
- DOI
- 10.21203/rs.3.rs-4485542/v1
